Zika Virus Testing Market Analysis

Zika Virus Testing Market Analysis

To get key market trends

  Download Free Sample

The zika virus testing market by test type is segmented into serological tests and molecular tests. The serological tests segment is further segmented into reverse transcription polymerase chain reaction (RT-PCR) and nucleic acid amplification testing (NAAT). The serological tests segment is categorized into enzyme-linked immune sorbent assay (ELISA) and plaque reduction and neutralization test (PRNT). The molecular tests segment is expected to witness CAGR of 7.8% by 2032..
 

For instance, real-time reverse transcription polymerase chain reaction (RT-PCR) is widely utilized for accurate and timely detection of zika virus RNA. Also, multiplex assays gaining popularity due to simultaneous detection of multiple pathogens including zika virus.
 

Moreover, point-of-care molecular diagnostic tests offer rapid results at the patient's bedside, while isothermal amplification methods provide simplified protocols and faster turnaround times. Thus, aforementioned advancements and availability of several testing techniques will propel segmental demand in the business. Further, automation and high-throughput systems streamline testing processes as well as ongoing research focuses on novel targets and biomarkers to enhance sensitivity and specificity are some of major factors contributing to segmental revenue gain.
 

The zika virus testing market by end user is categorized into hospitals, diagnostic centers, public health laboratory and others. Hospitals segment held largest revenue size accounting for over USD 70 million in 2022. The high revenue evolution is owing surge in the number of patients associated with zika virus infection. Growing availability and accessibility of novel technology into settings for detection of zika virus cases bolstering segmental expansion potential. Additionally, implementation of comprehensive surveillance systems to monitor the prevalence of the virus and identify potential outbreaks is predicted to accelerate segment growth in the market.
 

U.S. zika virus testing market accounted for over USD 40 million in 2022. Growing awareness and concern regarding the impact of zika virus on public health have been instrumental in driving the demand for zika virus testing. As, the U.S. being a popular travel destination, the high demand for zika virus testing owing to the need to screen individuals returning from regions with high zika virus prevalence.
 

In addition, favorable travel-related testing requirements and guidelines by the government and travel medicine providers will contribute to the development of the market. Further, sophisticated healthcare infrastructure, favorable reimbursement scenario, large presence of industry participants will boost the U.S. market in near future.